NEW YORK 1997-03-31 While shares of Columbia/HCA Healthcare Corp took a beating Monday following a federal probe and media reports about its billing practices , industry analysts continued to support the stock. Columbia/HCA lost 4-3/4 to 33 and was the heavily traded issue on the New York Stock Exchange. The stock is still good long-term. Analysts cautioned that the New York Times used its own methodology , which has not been verified by others in the healthcare industry , as the basis of its article. Columbia/HCA said it was not given the opportunity to review the New York Times' data and could not address the newspaper's findings. Analysts expect Columbia/HCA's stock to continue to face near-term pressure but said the company will remain a market leader over the long-term. _ The stock was in for a tough day today. ( ( New York newsdesk 212-859-1610 ) ) 